Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori.
Conclusions: Tegoprazan administration may improve the susceptibility of antimicrobial- resistant H. pylori, independent of acid suppression.
PMID: 33191308 [PubMed - as supplied by publisher]
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Gastroenterology | Helicobacter Pylori | Liver | Metronidazole | Potassium | Superbugs | Urology & Nephrology